H-CYTE Announces Publication of Positive Real-World Data Relating to the Use of Innovative Treatment (PRP-PBMC) Aimed at Helping Improve Overall Lung Health
June 29, 2021 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., June 29, 2021 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company focused on the field of regenerative medicine, today announced the publication of its...
Robert Greif named Chief Executive Officer of H-CYTE
September 29, 2020 17:30 ET
|
H-CYTE, Inc.
TAMPA, Fla., Sept. 29, 2020 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a developer of regenerative cellular therapeutics, announced today that Robert Greif has been named the company’s new...
H-CYTE Extends Rights Offering to 5:00 PM Eastern Time on Friday, September 11, 2020
September 03, 2020 08:30 ET
|
H-CYTE, Inc.
TAMPA, Fla., Sept. 03, 2020 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company that develops and implements innovative treatment options in regenerative medicine to help...
H-CYTE Extends Rights Offering to 5:00 PM Eastern Time on Friday, September 11, 2020
September 02, 2020 08:30 ET
|
H-CYTE, Inc.
TAMPA, Fla., Sept. 02, 2020 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB: HCYT), a medical biosciences company that develops and implements innovative treatment options in regenerative medicine to help...
H-CYTE Issues Letter to Shareholders
January 21, 2020 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., Jan. 21, 2020 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
November 18, 2019 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors
July 30, 2019 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors
July 29, 2019 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
H-CYTE Comments on Recent Promotional Activity
July 17, 2019 17:30 ET
|
H-CYTE, Inc.
TAMPA, Fla., July 17, 2019 (GLOBE NEWSWIRE) -- H-CYTE, INC. (OTCQB: HCYT), wishes to make, at the request of the OTC Markets Group Inc., the following release regarding certain market activity...
Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol
July 12, 2019 08:30 ET
|
Medovex Corp.
TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness of a change in the company’s name from “Medovex Corp.” to...